“Medscape is a terrific fit for QxMD,” said Daniel Schwartz, M.D., QxMD CEO & Medical Director. “The company shares our commitment to digital innovation that streamlines and enhances clinical practice and improves patient care. Through Medscape’s unparalleled reach and engagement, we will be able to have an even greater impact on physicians, health care professionals, and their patients.”
QxMD will continue to operate as an independent subsidiary of WebMD Health Corp. Terms of the transaction were not made public.
QxMD™ is a digital learning technology company that makes it easier for healthcare professionals (HCPs) to discover the latest evidence and decision support tools for use in clinical practice. The company’s HCP engagement platform comprises a library of trusted apps that provide millions of members with fast access to full-text research, continuing medical education (CME), and up-to-date tools that drive disease recognition and therapy optimization. Powered by a sophisticated personalization engine, the platform aggregates PubMed feeds, journal table of contents (TOCs), 450+ diagnostic tools, micro-CME courses and more. QxMD also serves other healthcare constituents such as hospitals, libraries, scholarly publishers, and nearly 50% of the world’s top-25 pharmaceutical companies.